Overview

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

Status:
Active, not recruiting
Trial end date:
2021-05-15
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the safe and efficacy of APR-246 in combination with azacitidine as well as to see complete remission of this patients
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Groupe Francophone des Myelodysplasies
Collaborators:
Aprea Therapeutics
Aprea Therapeutics AB
Treatments:
Azacitidine